Rezultati pretraživanja
  1. ⬇ Sell (-22%) for ⬇⬇ Strong Sell (-89%) for ⬇ Sell (-22%) for ⬆ Buy (11%) for ⬆⬆ Strong Buy (67%) for

  2. -$0.69 EPS Expected for Nektar Therapeutics This Quarter

  3. prije 12 sati

    We've found the sweet spot of this market...again: , , , , , , ...among others.

  4. prije 12 sati
    Odgovor korisniku/ci

    Nice...... also may want to keep an eye on ..... something has this thing moving.

  5. prije 12 sati

    now we commence the move back up 👍 looking out to May

  6. 4. velj

    ⬇⬇ Strong Sell (-67%) for ⬇ Sell (-11%) for ⬆ Buy (44%) for ⬇ Sell (0%) for ⬆⬆ Strong Buy (67%) for

  7. 4. velj

    Morning highest % above OR 30-min high, Up/Avg Gain of today's four 30-min bars, G/L % in previous 30-Min & Trading range % (Min $5, Vol > 750K, Opt Vol in any strike > 250):

  8. 4. velj

    Brokerages Anticipate Nektar Therapeutics Will Announce Quarterly Sales of $26.34 Million

  9. 4. velj

    $26.34 Million in Sales Expected for Nektar Therapeutics This Quarter

  10. 3. velj
  11. 3. velj

    Nektar call volume above normal and directionally bullish

  12. 3. velj

    Two bempeg manuscripts published and a Mizuho upgrade equal nice movement, on strong volume, it seems. Shares still buyable, imho. /long.

  13. 3. velj

    ⬇ Sell (-22%) for ⬆⬆ Strong Buy (56%) for ⬆⬆ Strong Buy (78%) for ⬆⬆ Strong Buy (78%) for ⬆ Buy (11%) for

  14. 3. velj
  15. 3. velj

    Watching this morning

  16. 3. velj

    Concerned parents rejoice. Aimmune Therapeutics received a FDA approval form its new peanut allergy drug. up strongly premarket. Also watching up gappers .

  17. 3. velj

    Mizuho analyst Difei Yang upgraded Nektar Therapeutics to Buy from Neutral with a price target of $35, up from $21

  18. 3. velj

    Mizuho Reaffirms Buy Rating for Nektar Therapeutics

  19. 3. velj

    Mizuho upgrades Nektar to Buy on 'good risk/reward' into cancer data

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.